Mebeverine Impurity 6
- CAS860441-09-4
- CatalogueRS-Z413G2D
- FormulaMoNiTeV
- MW333.2
On this page
structure on request
Product identification
| Product name | Mebeverine Impurity 6 |
|---|---|
| Catalogue No. | RS-Z413G2D |
| CAS No. | 860441-09-4 |
| Molecular formula | MoNiTeV |
| Molecular weight | 333.2 |
| Availability | Custom synthesis— made to order, typically 3–4 weeks |
| Standard type | General Reference Standards |
| Drug substance | Mebeverine |
| Also known as | STDPHARM |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-Z413G2D / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
Is the assigned value given on an “as is” basis?
How should this material be stored?
Do you supply pack sizes other than those listed?
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Mebeverine
- General Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-Z413G2D
- Request a quotation for RS-Z413G2D
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Mebeverine
All 30 further standards are listed here — every link is in the page, not loaded later.
-
Mebeverine
BACK ORDERRS-M148007 -
Mebeverine EP Impurity A
IN STOCKRS-M148002 -
Mebeverine EP Impurity C
IN STOCKRS-M148004 -
Mebeverine EP Impurity N
BACK ORDERRS-I001AGF -
Mebeverine Impurity F
IN STOCKRS-M148011 -
Mebeverine Impurity G
CUSTOM SYNTHESISRS-M148014 -
Mebeverine Impurity J
IN STOCKRS-M148010 -
Mebeverine Impurity O
IN STOCKRS-M148013 -
1-Chloro-4-phenylbutane
BACK ORDERRS-U006318 -
3'-Methoxypropiophenone
CUSTOM SYNTHESISRS-U010311 -
4-Bromobutyl 3,4-dimethoxybenzoate
IN STOCKRS-P141047 -
4-Methoxy-3-methylphenylacetone
IN STOCKRS-U100086 -
4’-Hydroxy-3’-methylacetophenone
IN STOCKRS-U067906 -
7-Methoxy-2,3,4,5-tetrahydro-1H-benzo[d]azepine hydrochloride
IN STOCKRS-Z001NOA -
Mebeverine Acid D5
IN STOCKRS-M148016 -
Mebeverine Alcohol-d5
IN STOCKRS-M148015 -
Mebeverine D6
BACK ORDERRS-M148005 -
Mebeverine D6
BACK ORDERRS-Z400S4B -
Mebeverine-d6 Hydrochloride
IN STOCKRS-M148003 -
N,N-Bis(2,2-Diethoxyethyl)Nitrous Amide
IN STOCKRS-I014307 -
N-ethyl-p-methoxy Phenyl Isopropyl amine
IN STOCKRS-U054380 -
O-Desmethyl Mebeverine Alcohol
IN STOCKRS-M148012 -
Veratric Acid-d6
IN STOCKRS-I115004 -
β-D-Glucopyranuronic acid, 1-(3,4-dimethoxybenzoate)
IN STOCKRS-U077634 -
Mebeverine Acid Impurity 1-d5 (Desmethyl Mebeverine Acid-d5)
IN STOCKRS-Z412MAQ -
Mebeverine Impurity 6
BACK ORDERRS-M148008 -
Mebeverine Impurity 8
IN STOCKRS-U211O6F -
Mebeverine Impurity 27
IN STOCKRS-M148009 -
Mebeverine Impurity 33
IN STOCKRS-M148001 -
Mebeverine Impurity 34
IN STOCKRS-M148006
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.













![Chemical structure of 7-Methoxy-2,3,4,5-tetrahydro-1H-benzo[d]azepine hydrochloride](/structures/w4/QTFBRRKMULNOSW-UHFFFAOYSA-N.webp?v=8)













